tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Astec LifeSciences Re-appoints Nandkumar Dhekne as Independent Director

Story Highlights
Astec LifeSciences Re-appoints Nandkumar Dhekne as Independent Director

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Astec Lifesciences Limited ( (IN:ASTEC) ) is now available.

Astec LifeSciences Limited has announced the re-appointment of Mr. Nandkumar Dhekne as a Non-Executive & Independent Director for a second term of five years, starting from December 18, 2025, subject to shareholder approval. This strategic move leverages Mr. Dhekne’s extensive experience in operations management and leadership across the Asia Pacific region, potentially strengthening the company’s governance and strategic direction.

More about Astec Lifesciences Limited

Average Trading Volume: 2,086

Technical Sentiment Signal: Sell

Current Market Cap: 17.93B INR

Learn more about ASTEC stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1